In vitro pharmacokinetic characterization of mulberroside A, the main polyhydroxylated stilbene in mulberry (Morus alba L.), and its bacterial metabolite oxyresveratrol in traditional oral use

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 9, 2012, Pages 2299-2308

  Mei, Mei ^a   Ruan, Jian Qing ^a   Wu, Wen Jin ^a   Zhou, Rui Na ^a   Lei, Pui Cheong ^c   Zhao, Hai Yu ^a   Yan, Ru ^a   Wang, Yi Tao ^a,b  

^a University of Macau   (Macao)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c Macao Special Administrative Region of the People's Republic of China   (Macao)

Author keywords

Deglycosylation; Glucuronidation; Hydroxystilbenes; Intestinal bacteria; Morus alba L.; Mulberroside A; Oxyresveratrol; Permeability

Indexed keywords

DEGLYCOSYLATION; GLUCURONIDATION; HYDROXYSTILBENES; INTESTINAL BACTERIA; MORUS ALBA; MULBERROSIDE A; OXYRESVERATROL;

BIOMOLECULES; CELLS; MECHANICAL PERMEABILITY; METABOLITES; PHARMACOKINETICS; PLANTS (BOTANY); RATS;

BACTERIA;

DISACCHARIDE; GLUCURONIDE; MULBERROSIDE A; PLANT EXTRACT; PUAG-HAAD; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; BACTERIUM; CHEMISTRY; COMPARATIVE STUDY; HUMAN; IN VITRO STUDY; INTESTINE; LIVER; METABOLISM; MICROBIOLOGY; MORUS; PUAG HAAD; RAT; SPECIES DIFFERENCE;

ANIMALS; BACTERIA; DISACCHARIDES; GLUCURONIDES; HUMANS; INTESTINES; LIVER; MORUS; PLANT EXTRACTS; RATS; SPECIES SPECIFICITY; STILBENES;

BACTERIA (MICROORGANISMS); MORUS (ANGIOSPERM); MORUS ALBA; RATTUS;

EID: 84859762574     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf204495t     Document Type: Article

References (30)

1. The State Pharmacopoeia Commission of P. R. China. Pharmacopoeia of People's Republic of China; Chemical Industry Press: Beijing, China, 2010.
2. Naowaboot, J.; Pannangpetch, P.; Kukongviriyapan, V.; Kongyingyoes, B.; Kukongviriyapan, U. Antihyperglycemic, antioxidant and antiglycation activities of mulberry leaf extract in streptozotocin-induced chronic diabetic rats. Plant Foods Hum. Nutr. 2009, 64, 116-121.
3. Lee, Y. J.; Choi, D. H.; Kim, E. J.; Kim, H. Y.; Kwon, T. O.; Kang, D. G.; Lee, H. S. Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet. Am. J. Chin. Med. 2011, 39, 39-52.
4. Chang, L. W.; Juang, L. J.; Wang, B. S.; Wang, M. Y.; Tai, H. M.; Hung, W. J.; Chen, Y. J.; Huang, M. H. Antioxidant and antityrosinase activity of mulberry (Morus alba L.) twigs and root bark. Food Chem. Toxicol. 2011, 49, 785-790.
5. Katsube, T.; Yamasaki, M.; Shiwaku, K.; Ishijima, T.; Matsumoto, I.; Abe, K.; Yamasaki, Y. Effect of flavonol glycoside in mulberry (Morus alba L.) leaf on glucose metabolism and oxidative stress in liver in diet-induced obese mice. J. Sci. Food. Agric. 2010, 90, 2386-2392.
6. Asano, N.; Yamashita, T.; Yasuda, K.; Ikeda, K.; Kizu, H.; Kameda, Y.; Kato, A.; Nash, R. J. Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J. Agric. Food Chem. 2001, 49, 4208-4213. (Pubitemid 32896411)
7. Piao, S. J.; Qu, G. X.; Qiu, F. Chemical constituents of the water extract from Mori Cortex. Zhongguo Yaowu Huaxue Zazhi 2006, 16, 40-45.
8. Wang, C. P.; Wang, Y.; Wang, X.; Zhang, X.; Ye, J. F.; Hu, L. S.; Kong, L. D. Mulberroside A possesses potent uricosuric and nephroprotective effects in hyperuricemic mice. Planta Med. 2011, 77, 786-794.
9. Kim, J. K.; Kim, M.; Cho, S. G.; Kim, M. K.; Kim, S. W.; Lim, Y. H. Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition. J. Ind. Microbiol. Biotechnol. 2010, 37, 631-637.
10. Qiu, F.; Komatsu, K.; Saito, K.; Kawasaki, K.; Yao, X.; Kano, Y. Pharmacological properties of traditional medicines. XXII. Pharmacokinetic study of mulberroside A and its metabolites in rat. Biol. Pharm. Bull. 1996, 19, 1463-1467. (Pubitemid 26403253)
11. Zhaxi, M.; Chen, L.; Li, X.; Komatsu, K.; Yao, X.; Qiu, F. Three major metabolites of mulberroside a in rat intestinal contents and feces. Planta Med. 2010, 76, 362-364.
12. Wang, R. F.; Cao, W. W.; Cerniglia, C. E. PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl. Environ. Microb. 1996, 62, 1242-1247. (Pubitemid 26113201)
13. Blaut, M.; Clavel, T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J. Nutr. 2007, 137, 751S-755S. (Pubitemid 46397515)
14. Turpeinen, M.; Ghiciuc, C.; Opritoui, M.; Tursas, L.; Pelkonen, O.; Pasanen, M. Predictive value of animal models for human cytochrome P450 (CYP) mediated metabolism: Comparative study in vitro. Xenobiotica 2007, 37, 1367-1377. (Pubitemid 350146687)
15. Liang, S. C.; Ge, G. B.; Liu, H. X.; Shang, H. T.; Wei, H.; Fang, Z. Z.; Zhu, L. L.; Mao, Y. X.; Yang, L. Determination of propofol UDP- glucuronosyltransferase (UGT) activities in hepatic microsomes from different species by UFLC-ESI-MS. J. Pharm. Biomed. 2011, 54, 236-241.
16. Lowry, O. H; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
17. Ruan, J. Q.; Leong, W. I.; Yan, R.; Wang, Y. T. Characterization of metabolism and in vitro permeability study of notoginsenoside R1from Radix Notoginseng. J. Agric. Food Chem. 2010, 58, 5770-5776.
18. Yan, R.; Ko, N. L.; Lin, G.; Tam, Y. K. Low oral bioavailability and pharmacokinetics of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat. Drug Metab. Dispos. 2008, 36, 400-408. (Pubitemid 351185754)
19. Voigt, W. Sulforhodamine B assay and chemosensitivity. Methods Mol. Med. 2005, 110, 39-48.
20. Huang, H.; Chen, G.; Lu, Z.; Zhang, J.; Guo, D. A. Identification of seven metabolites of oxyresveratrol in rat urine and bile using liquid chromatography/tandem mass spectrometry. Biomed. Chromatogr. 2010, 24, 426-432.
21. Chao, J.; Yu, M. S.; Ho, Y. S.; Wang, M.; Chang, R. C. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radical Biol. Med. 2008, 45, 1019-1026.
22. Lorenz, P.; Roychowdhury, S.; Engelmann, M.; Wolf, G.; Horn, T. F. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: Effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide-Biol. Chem. 2003, 9, 64-76. (Pubitemid 37386375)
23. Kim, Y. M.; Yun, J.; Lee, C. K.; Lee, H.; Min, K. R.; Kim, Y. Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J. Biol. Chem. 2002, 277, 16340-16344. (Pubitemid 34967923)
24. Liu, Y.; Hu, M. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab. Dispos. 2002, 30, 370-377. (Pubitemid 34263820)
25. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
26. Henry, C.; Vitrac, X.; Decendit, A.; Ennamany, R.; Krisa, S.; Mérillon, J. M. Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells. J. Agric. Food Chem. 2005, 53, 798-803. (Pubitemid 40194406)
27. Li, Y.; Revalde, J. L.; Reid, G.; Paxton, J. W. Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metab. Rev. 2010, 42, 590-611.
28. Maier-Salamon, A.; Hagenauer, B.; Wirth, M.; Gabor, F.; Szekeres, T.; Jäger, W. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm. Res.-Dordr. 2006, 23, 2107-2115.
29. Sabolovic, N.; Humbert, A. C.; Radominska-Pandya, A.; Magdalou, J. Resveratrol is efficiently glucuronidated by UDPglucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells. Biopharm. Drug Dispos. 2006, 27, 181-189. (Pubitemid 43797114)
30. Aumont, V.; Krisa, S.; Battaglia, E.; Netter, P.; Richard, T.; Mérillon, J. M.; Magdalou, J.; Sabolovic, N. Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Arch. Biochem. Biophys. 2001, 393, 281-289. (Pubitemid 32907185)